Sickle cell bone disease: Response to vitamin D and calcium
- 9 October 2007
- journal article
- clinical trial
- Published by Wiley in American Journal of Hematology
- Vol. 83 (4) , 271-274
Abstract
Bone disease with osteoporosis and osteomalacia are common in sickle cell disease (SCD). Some patients have vitamin D deficiency and low bone mineral density (BMD). The role of vitamin D and calcium supplementation to restore bone health in SCD has not been well studied. In 14 adults with SCD, we measured 25(OH)D (25‐hydroxyvitamin D) and BMD at the femoral neck, lumbar spine, and distal third of the ulna plus radius, along with markers of bone resorption (CTx; C‐terminal component of pro‐collagen type I) and bone formation (osteocalcin) before and after 12 months of vitamin D2 and calcium carbonate treatment. Pretreatment, all patients were vitamin D deficient with a mean 25(OH)D level of 10.7 ± 4.7 ng/ml, had low BMD at the lumbar spine (L‐spine), 0.87 ± 0.11 g/cm2 (mean Z‐score of –2.6 3 ± 0.71 SD and T score of –2.31 ± 0.75 SD), femoral neck, 0.8 ± 0.18 g/cm2 (mean Z‐score –1.36 ± 0.84, T‐score –1.14 ± 0.75), and the distal radius and ulna, 0.6 ± 0.17 g/cm2 (mean Z‐score –1.18 ± 0.79, T‐score –1.01 ± 0.74) and had elevated CTx (0.87 ± 0.5 ng/ml) and osteocalcin levels (12.3 ± 3.7 ng/μl). After treatment, all patients corrected their 25(OH)D level (38.8 ± 13.9 ng/ml) (P < 0.001) with a 3.6% ± 3.9% increase in BMD at the L‐spine (P = 0.009), 4.6% ± 8.5% increase at the femoral neck (P = 0.05) and 6.5% ± 12.6% increase at the distal radius plus ulna (P = 0.09). CTx, osteocalcin, and PTH(i) levels were unchanged. Treatment of adult SCD with vitamin D and calcium can restore 25(OH)D levels to normal and improve BMD, but, markers of bone resorption remained unchanged. Screening for vitamin D deficiency and BMD in SCD patients seems warranted. Am. J. Hematol., 2008.Keywords
This publication has 34 references indexed in Scilit:
- Bone mass density in adults with sickle cell diseaseBritish Journal of Haematology, 2007
- Deconstructing sickle cell disease: Reappraisal of the role of hemolysis in the development of clinical subphenotypesBlood Reviews, 2007
- Modifier genes and sickle cell anemiaCurrent Opinion in Hematology, 2006
- High prevalence and correlates of low bone mineral density in young adults with sickle cell diseaseAmerican Journal of Hematology, 2006
- The hematological etiology of osteoporosisMedical Hypotheses, 2006
- Bone mineral density in children with sickle cell anemiaPediatric Blood & Cancer, 2005
- Prevalence of Severe Hypovitaminosis D in Patients With Persistent, Nonspecific Musculoskeletal PainMayo Clinic Proceedings, 2003
- Serum Calcium, Parathyroid Hormone, and Vitamin D Status in Children and Young Adults with Sickle Cell DiseaseAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1993
- INCREASED SKIN PIGMENT REDUCES THE CAPACITY OF SKIN TO SYNTHESISE VITAMIN D3The Lancet, 1982
- JOINT MANIFESTATIONS OF SICKLE CELL DISEASEMedicine, 1974